S

SWK Holdings Corp
NASDAQ:SWKH

Watchlist Manager
SWK Holdings Corp
NASDAQ:SWKH
Watchlist
Price: 17.28 USD -0.12% Market Closed
Market Cap: 209.1m USD

SWK Holdings Corp
Total Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

SWK Holdings Corp
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
S
SWK Holdings Corp
NASDAQ:SWKH
Total Assets
$289.4m
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
5%
LM Funding America Inc
NASDAQ:LMFA
Total Assets
$60.2m
CAGR 3-Years
-4%
CAGR 5-Years
36%
CAGR 10-Years
26%
A-Mark Precious Metals Inc
NASDAQ:AMRK
Total Assets
$2.6B
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
21%
California First Leasing Corp
OTC:CFNB
Total Assets
$281.5m
CAGR 3-Years
9%
CAGR 5-Years
1%
CAGR 10-Years
-9%
S
Standard Premium Finance Holdings Inc
OTC:SPFX
Total Assets
$65.8m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SUI Group Holdings Ltd
NASDAQ:SUIG
Total Assets
$429.1m
CAGR 3-Years
172%
CAGR 5-Years
109%
CAGR 10-Years
48%
No Stocks Found

SWK Holdings Corp
Glance View

Market Cap
209m USD
Industry
Financial Services

SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company is headquartered in Dallas, Texas and currently employs 35 full-time employees. The firm is focused on providing various capital solutions to a range of life science companies, institutions and inventors. The firm operates through two segments: Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. In addition, through its wholly owned subsidiary, SWK Advisors LLC, it provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. Through its subsidiary, Enteris BioPharma, Inc., its Pharmaceutical Development segment offers formulation solutions built around its oral drug delivery technology, the Peptelligence platform.

SWKH Intrinsic Value
24.75 USD
Undervaluation 30%
Intrinsic Value
Price
S

See Also

What is SWK Holdings Corp's Total Assets?
Total Assets
289.4m USD

Based on the financial report for Sep 30, 2025, SWK Holdings Corp's Total Assets amounts to 289.4m USD.

What is SWK Holdings Corp's Total Assets growth rate?
Total Assets CAGR 10Y
5%

Over the last year, the Total Assets growth was -10%.

Back to Top